486 related articles for article (PubMed ID: 32821097)
21. Integrated platform of oxygen self-enriched nanovesicles: SP94 peptide-directed chemo/sonodynamic therapy for liver cancer.
Zhang W; Han B; Gao C; Liu X; Peng Y; Gong C; Hu D; Wang N; Tang S; Zhang B; Zhao M; Peng H
Eur J Pharm Biopharm; 2022 Oct; 179():206-220. PubMed ID: 36150614
[TBL] [Abstract][Full Text] [Related]
22. Mitochondria-targeted nanoplatforms for enhanced photodynamic therapy against hypoxia tumor.
Wen J; Luo Y; Gao H; Zhang L; Wang X; Huang J; Shang T; Zhou D; Wang D; Wang Z; Li P; Wang Z
J Nanobiotechnology; 2021 Dec; 19(1):440. PubMed ID: 34930284
[TBL] [Abstract][Full Text] [Related]
23. Biodegradable reduce expenditure bioreactor for augmented sonodynamic therapy via regulating tumor hypoxia and inducing pro-death autophagy.
Zou W; Hao J; Wu J; Cai X; Hu B; Wang Z; Zheng Y
J Nanobiotechnology; 2021 Dec; 19(1):418. PubMed ID: 34903226
[TBL] [Abstract][Full Text] [Related]
24. Nanoarchitectonics with metal-organic frameworks and platinum nanozymes with improved oxygen evolution for enhanced sonodynamic/chemo-therapy.
Ren Q; Yu N; Wang L; Wen M; Geng P; Jiang Q; Li M; Chen Z
J Colloid Interface Sci; 2022 May; 614():147-159. PubMed ID: 35091144
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-Adapted Sono-chemodynamic Treatment of Orthotopic Pancreatic Carcinoma Using Copper Metal-Organic Frameworks Loaded with an Ultrasound-Induced Free Radical Initiator.
Sun Y; Cao J; Wang X; Zhang C; Luo J; Zeng Y; Zhang C; Li Q; Zhang Y; Xu W; Zhang T; Huang P
ACS Appl Mater Interfaces; 2021 Aug; 13(32):38114-38126. PubMed ID: 34357760
[TBL] [Abstract][Full Text] [Related]
26. pH-Responsive Nanoparticles for Enhanced Antitumor Activity by High-Intensity Focused Ultrasound Therapy Combined with Sonodynamic Therapy.
Gao H; Wang Z; Tan M; Liu W; Zhang L; Huang J; Cao Y; Li P; Wang Z; Wen J; Shang T; Ran H
Int J Nanomedicine; 2022; 17():333-350. PubMed ID: 35115772
[TBL] [Abstract][Full Text] [Related]
27. Co-Delivery of Metformin Enhances the Antimultidrug Resistant Tumor Effect of Doxorubicin by Improving Hypoxic Tumor Microenvironment.
Li Y; Luo J; Lin MT; Zhi P; Guo WW; Han M; You J; Gao JQ
Mol Pharm; 2019 Jul; 16(7):2966-2979. PubMed ID: 31095914
[TBL] [Abstract][Full Text] [Related]
28. Intelligent Hollow Pt-CuS Janus Architecture for Synergistic Catalysis-Enhanced Sonodynamic and Photothermal Cancer Therapy.
Liang S; Deng X; Chang Y; Sun C; Shao S; Xie Z; Xiao X; Ma P; Zhang H; Cheng Z; Lin J
Nano Lett; 2019 Jun; 19(6):4134-4145. PubMed ID: 31084016
[TBL] [Abstract][Full Text] [Related]
29. A pH/Ultrasound dual-response biomimetic nanoplatform for nitric oxide gas-sonodynamic combined therapy and repeated ultrasound for relieving hypoxia.
An J; Hu YG; Li C; Hou XL; Cheng K; Zhang B; Zhang RY; Li DY; Liu SJ; Liu B; Zhu D; Zhao YD
Biomaterials; 2020 Feb; 230():119636. PubMed ID: 31785776
[TBL] [Abstract][Full Text] [Related]
30. Metal-Organic Framework (MOF)-Based Ultrasound-Responsive Dual-Sonosensitizer Nanoplatform for Hypoxic Cancer Therapy.
Zhang C; Xin L; Li J; Cao J; Sun Y; Wang X; Luo J; Zeng Y; Li Q; Zhang Y; Zhang T; Huang P
Adv Healthc Mater; 2022 Jan; 11(2):e2101946. PubMed ID: 34706160
[TBL] [Abstract][Full Text] [Related]
31. Facile Synthesis of a Multifunctional Porous Organic Polymer Nanosonosensitizer (mHM@HMME) for Enhanced Cancer Sonodynamic Therapy.
Li M; Liu Z; Tang J; Cheng L; Xue Y; Liu Y; Liu J
ACS Appl Mater Interfaces; 2024 Jun; 16(22):28104-28117. PubMed ID: 38769350
[TBL] [Abstract][Full Text] [Related]
32. A hypoxia responsive nanoassembly for tumor specific oxygenation and enhanced sonodynamic therapy.
Yang K; Yue L; Yu G; Rao L; Tian R; Wei J; Yang Z; Sun C; Zhang X; Xu M; Yuan Z; Chen X; Wang R
Biomaterials; 2021 Aug; 275():120822. PubMed ID: 34062419
[TBL] [Abstract][Full Text] [Related]
33. Biomimetic Decoy Inhibits Tumor Growth and Lung Metastasis by Reversing the Drawbacks of Sonodynamic Therapy.
Zhao H; Zhao B; Li L; Ding K; Xiao H; Zheng C; Sun L; Zhang Z; Wang L
Adv Healthc Mater; 2020 Jan; 9(1):e1901335. PubMed ID: 31762228
[TBL] [Abstract][Full Text] [Related]
34. Lipid bilayer-based biological nanoplatforms for sonodynamic cancer therapy.
Li S; Mok GSP; Dai Y
Adv Drug Deliv Rev; 2023 Nov; 202():115110. PubMed ID: 37820981
[TBL] [Abstract][Full Text] [Related]
35. Bioreducible exosomes encapsulating glycolysis inhibitors potentiate mitochondria-targeted sonodynamic cancer therapy via cancer-targeted drug release and cellular energy depletion.
Nguyen Cao TG; Truong Hoang Q; Kang JH; Kang SJ; Ravichandran V; Rhee WJ; Lee M; Ko YT; Shim MS
Biomaterials; 2023 Oct; 301():122242. PubMed ID: 37473534
[TBL] [Abstract][Full Text] [Related]
36. Defeating relapsed and refractory malignancies through a nano-enabled mitochondria-mediated respiratory inhibition and damage pathway.
Yang Z; Wang J; Liu S; Li X; Miao L; Yang B; Zhang C; He J; Ai S; Guan W
Biomaterials; 2020 Jan; 229():119580. PubMed ID: 31707296
[TBL] [Abstract][Full Text] [Related]
37. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
[TBL] [Abstract][Full Text] [Related]
38. Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer.
Chen J; Luo H; Liu Y; Zhang W; Li H; Luo T; Zhang K; Zhao Y; Liu J
ACS Nano; 2017 Dec; 11(12):12849-12862. PubMed ID: 29236476
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-specific therapeutic agents delivery nanotheranostics: A sequential strategy for ultrasound mediated on-demand tritherapies and imaging of cancer.
Feng Q; Li Y; Yang X; Zhang W; Hao Y; Zhang H; Hou L; Zhang Z
J Control Release; 2018 Apr; 275():192-200. PubMed ID: 29474964
[TBL] [Abstract][Full Text] [Related]
40. Sequential Ultrasound-Triggered and Hypoxia-Sensitive Nanoprodrug for Cascade Amplification of Sonochemotherapy.
Zhuang F; Ma Q; Dong C; Xiang H; Shen Y; Sun P; Li C; Chen Y; Lu B; Chen Y; Huang B
ACS Nano; 2022 Apr; 16(4):5439-5453. PubMed ID: 35357810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
